1-naphthyl isothiocyanate multiple interactions ISO RGD:1320897 6480464 O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1, 2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA] CTD PMID:15913567 1-naphthyl isothiocyanate increases expression ISO RGD:1320897 6480464 1-Naphthylisothiocyanate results in increased expression of RIPK1 mRNA CTD PMID:15913567 17alpha-ethynylestradiol increases expression ISO RGD:1320897 6480464 Ethinyl Estradiol results in increased expression of RIPK1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1320897 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK1 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1320896 6480464 Estradiol results in decreased expression of RIPK1 mRNA CTD PMID:23373633 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1320896 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320897 6480464 Tetrachlorodibenzodioxin results in increased expression of RIPK1 mRNA CTD PMID:12167310 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RIPK1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320897 6480464 Tetrachlorodibenzodioxin affects the expression of RIPK1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320897 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RIPK1 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of RIPK1 mRNA CTD PMID:21346803 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene results in decreased expression of RIPK1 mRNA CTD PMID:22584684 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin analog results in increased expression of RIPK1 protein CTD PMID:29860048 3-chloropropane-1,2-diol increases expression ISO RGD:1320897 6480464 alpha-Chlorohydrin analog results in increased expression of RIPK1 mRNA, alpha-Chlorohydrin analog results in increased expression of RIPK1 protein CTD PMID:29860048 4,4'-diaminodiphenylmethane increases expression ISO RGD:1320897 6480464 4, 4'-diaminodiphenylmethane results in increased expression of RIPK1 mRNA CTD PMID:18648102 4-nitrophenol decreases expression ISO RGD:1320897 6480464 4-nitrophenol results in decreased expression of RIPK1 mRNA CTD PMID:34673133 5-fluorouracil increases expression ISO RGD:1320896 6480464 Fluorouracil results in increased expression of RIPK1 mRNA CTD PMID:34151400 acrolein multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in increased expression of RIPK1 protein CTD PMID:24847785 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of RIPK1 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1320896 6480464 Acrylamide results in increased expression of RIPK1 mRNA CTD PMID:32763439 adenosine multiple interactions ISO RGD:1320896 6480464 [Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein CTD PMID:24224954 aflatoxin B1 increases expression ISO RGD:1320897 6480464 Aflatoxin B1 results in increased expression of RIPK1 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1320896 6480464 Tretinoin results in increased expression of RIPK1 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO RGD:1320896 6480464 Antirheumatic Agents results in decreased expression of RIPK1 mRNA CTD PMID:24449571 arsenous acid increases cleavage ISO RGD:1320896 6480464 Arsenic Trioxide results in increased cleavage of RIPK1 protein CTD PMID:15314284 atazanavir sulfate multiple interactions ISO RGD:1320896 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA CTD PMID:32152650 benzene increases expression ISO RGD:1320896 6480464 Benzene results in increased expression of RIPK1 mRNA CTD PMID:33064461 benzo[a]pyrene increases expression ISO RGD:1320896 6480464 Benzo(a)pyrene results in increased expression of RIPK1 mRNA CTD PMID:22316170 benzo[a]pyrene multiple interactions ISO RGD:1320897 6480464 Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK1 protein] CTD PMID:35777681 benzo[a]pyrene affects expression ISO RGD:1320897 6480464 Benzo(a)pyrene affects the expression of RIPK1 protein CTD PMID:35777681 benzo[a]pyrene increases methylation ISO RGD:1320896 6480464 Benzo(a)pyrene results in increased methylation of RIPK1 promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1320897 6480464 Diethylhexyl Phthalate results in increased expression of RIPK1 mRNA, Diethylhexyl Phthalate results in increased expression of RIPK1 protein CTD PMID:35659966 bisphenol A increases expression ISO RGD:1320897 6480464 bisphenol A results in increased expression of RIPK1 mRNA CTD PMID:26063408 bisphenol A increases methylation ISO RGD:1320896 6480464 bisphenol A results in increased methylation of RIPK1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1320897 6480464 bisphenol A results in decreased expression of RIPK1 mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RIPK1 mRNA CTD PMID:25181051 bortezomib increases expression ISO RGD:1320897 6480464 Bortezomib results in increased expression of RIPK1 protein CTD PMID:26769846 bortezomib decreases expression ISO RGD:1320896 6480464 Bortezomib results in decreased expression of RIPK1 mRNA CTD PMID:20471514 C.I. Natural Red 20 multiple interactions ISO RGD:1320897 6480464 shikonin promotes the reaction [RIPK1 protein binds to RIPK3 protein] CTD PMID:23261677 caffeine decreases phosphorylation ISO RGD:1320896 6480464 Caffeine results in decreased phosphorylation of RIPK1 protein CTD PMID:35688186 cannabidiol increases expression ISO RGD:1320896 6480464 Cannabidiol results in increased expression of RIPK1 mRNA CTD PMID:31801206 cannabidiol multiple interactions ISO RGD:1320896 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of RIPK1 mRNA CTD PMID:30096889 carbon nanotube increases expression ISO RGD:1320897 6480464 Nanotubes more ... CTD PMID:25554681 ceruletide increases cleavage EXP 6480464 Ceruletide results in increased cleavage of RIPK1 protein CTD PMID:16339139 chenodeoxycholic acid multiple interactions ISO RGD:1320896 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA more ... CTD PMID:32152650 cisplatin increases expression ISO RGD:1320897 6480464 Cisplatin results in increased expression of RIPK1 mRNA, Cisplatin results in increased expression of RIPK1 protein CTD PMID:21151649 , PMID:26546572 cisplatin multiple interactions ISO RGD:1320897 6480464 4-methyl-N1-(3-phenylpropyl)benzene-1, 2-diamine inhibits the reaction [Cisplatin results in increased expression of RIPK1 protein] CTD PMID:26546572 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of RIPK1 mRNA CTD PMID:17898221 copper atom multiple interactions ISO RGD:1320896 6480464 [Chelating Agents binds to Copper] which results in increased expression of RIPK1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1320896 6480464 [Chelating Agents binds to Copper] which results in increased expression of RIPK1 mRNA CTD PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1320896 6480464 Copper Sulfate results in decreased expression of RIPK1 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1320896 6480464 coumarin results in increased phosphorylation of RIPK1 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:1320897 6480464 Asbestos, Crocidolite results in decreased expression of RIPK1 mRNA CTD PMID:29279043 curcumin multiple interactions ISO RGD:1320896 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of RIPK1 mRNA] CTD PMID:23452621 cyclosporin A increases expression ISO RGD:1320896 6480464 Cyclosporine results in increased expression of RIPK1 mRNA CTD PMID:32152650 cyclosporin A multiple interactions ISO RGD:1320896 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA CTD PMID:32152650 deoxycholic acid multiple interactions ISO RGD:1320896 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA more ... CTD PMID:32152650 dextran sulfate multiple interactions ISO RGD:1320897 6480464 dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of RIPK1 protein] CTD PMID:29496522 dextran sulfate increases expression ISO RGD:1320897 6480464 Dextran Sulfate results in increased expression of RIPK1 protein CTD PMID:29496522 diarsenic trioxide increases cleavage ISO RGD:1320896 6480464 Arsenic Trioxide results in increased cleavage of RIPK1 protein CTD PMID:15314284 dibutyl phthalate increases expression ISO RGD:1320897 6480464 Dibutyl Phthalate results in increased expression of RIPK1 mRNA CTD PMID:21266533 Dihydrotanshinone I multiple interactions ISO RGD:1320897 6480464 dihydrotanshinone I inhibits the reaction [[Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of RIPK1 protein modified form], dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of RIPK1 protein] CTD PMID:29496522 dioxygen increases expression ISO RGD:1320896 6480464 Oxygen deficiency results in increased expression of RIPK1 mRNA CTD PMID:23452621 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of RIPK1 protein CTD PMID:29605020 dioxygen multiple interactions ISO RGD:1320896 6480464 3 more ... CTD PMID:23452621 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of RIPK1 protein modified form CTD PMID:34713381 doxorubicin multiple interactions EXP 6480464 SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of RIPK1 protein modified form] CTD PMID:34713381 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of RIPK1 protein CTD PMID:34713381 doxorubicin multiple interactions ISO RGD:1320897 6480464 SIRT6 protein promotes the reaction [Doxorubicin results in decreased expression of RIPK1 protein] CTD PMID:34713381 ethanol decreases expression ISO RGD:1320897 6480464 Ethanol results in decreased expression of RIPK1 mRNA, Ethanol results in decreased expression of RIPK1 protein CTD PMID:26769846 ethanol affects expression ISO RGD:1320897 6480464 Ethanol affects the expression of RIPK1 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1320897 6480464 4-O-methylhonokiol inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in decreased expression of RIPK1 mRNA], [Ethanol co-treated with Carbon Tetrachloride] results in decreased expression of RIPK1 mRNA CTD PMID:28689299 ethanol increases expression ISO RGD:1320896 6480464 Ethanol results in increased expression of RIPK1 protein CTD PMID:30853489 , PMID:34474091 ethanol multiple interactions ISO RGD:1320896 6480464 Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein] more ... CTD PMID:30853489 , PMID:34474091 fenpyroximate decreases expression ISO RGD:1320896 6480464 fenpyroximate results in decreased expression of RIPK1 mRNA CTD PMID:33512557 ferric oxide multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in increased expression of RIPK1 protein CTD PMID:24847785 fingolimod hydrochloride multiple interactions ISO RGD:1320896 6480464 necrostatin-1 inhibits the reaction [Fingolimod Hydrochloride results in increased expression of RIPK1 protein] CTD PMID:25939952 fingolimod hydrochloride increases expression ISO RGD:1320896 6480464 Fingolimod Hydrochloride results in increased expression of RIPK1 protein CTD PMID:25939952 furosemide affects expression EXP 6480464 Furosemide affects the expression of RIPK1 mRNA CTD PMID:17497460 gallic acid multiple interactions ISO RGD:1320896 6480464 Gallic Acid inhibits the reaction [Ethanol results in increased expression of RIPK1 protein] CTD PMID:30853489 genistein multiple interactions ISO RGD:1320896 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of RIPK1 mRNA] CTD PMID:23452621 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RIPK1 mRNA CTD PMID:22061828 glycochenodeoxycholic acid multiple interactions ISO RGD:1320896 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA more ... CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:1320896 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA more ... CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:1320896 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA more ... CTD PMID:32152650 glyphosate decreases expression ISO RGD:1320896 6480464 glyphosate results in decreased expression of RIPK1 mRNA CTD PMID:31295307 homocysteine multiple interactions ISO RGD:1320896 6480464 [Adenosine co-treated with Homocysteine co-treated with TNF protein] results in increased cleavage of RIPK1 protein CTD PMID:24224954 hydralazine multiple interactions ISO RGD:1320896 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA CTD PMID:17183730 ivermectin decreases expression ISO RGD:1320896 6480464 Ivermectin results in decreased expression of RIPK1 protein CTD PMID:32959892 kaempferol multiple interactions ISO RGD:1320897 6480464 kaempferol inhibits the reaction [propacetamol results in increased expression of RIPK1 protein] CTD PMID:29574133 leflunomide decreases expression ISO RGD:1320896 6480464 leflunomide results in decreased expression of RIPK1 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1320897 6480464 [Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of RIPK1 protein modified form more ... CTD PMID:29496522 , PMID:30633930 luteolin 7-O-beta-D-glucoside increases expression ISO RGD:1320896 6480464 luteolin-7-glucoside results in increased expression of RIPK1 protein CTD PMID:34165247 maneb multiple interactions ISO RGD:1320897 6480464 [Maneb co-treated with Paraquat] results in increased expression of RIPK1 mRNA, Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of RIPK1 mRNA] CTD PMID:23963992 mangiferin decreases expression ISO RGD:1320897 6480464 mangiferin results in decreased expression of RIPK1 mRNA CTD PMID:15135318 Melarsoprol multiple interactions ISO RGD:1320896 6480464 Melarsoprol results in decreased expression of and results in increased cleavage of RIPK1 protein CTD PMID:15314284 melatonin multiple interactions ISO RGD:1320897 6480464 Melatonin inhibits the reaction [sodium arsenite results in increased expression of RIPK1 protein] CTD PMID:29763682 metformin multiple interactions ISO RGD:1320896 6480464 [Simvastatin co-treated with Metformin] promotes the reaction [RIPK3 protein binds to RIPK1 protein] more ... CTD PMID:25412314 methamidophos decreases expression ISO RGD:1320896 6480464 methamidophos results in decreased expression of RIPK1 mRNA CTD PMID:26688254 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of RIPK1 mRNA CTD PMID:22584684 methidathion decreases expression ISO RGD:1320897 6480464 methidathion results in decreased expression of RIPK1 mRNA CTD PMID:34813904 methoxyacetic acid affects expression EXP 6480464 methoxyacetic acid affects the expression of RIPK1 mRNA CTD PMID:20864626 methyl methanesulfonate increases expression ISO RGD:1320896 6480464 Methyl Methanesulfonate results in increased expression of RIPK1 mRNA CTD PMID:23649840 Myrtucommulone A decreases expression ISO RGD:1320897 6480464 myrtucommulone A results in decreased expression of RIPK1 mRNA CTD PMID:26032814 N-acetyl-L-cysteine multiple interactions ISO RGD:1320897 6480464 Acetylcysteine affects the reaction [Benzo(a)pyrene affects the expression of RIPK1 protein] CTD PMID:35777681 nefazodone multiple interactions ISO RGD:1320896 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RIPK1 mRNA CTD PMID:32152650 nefazodone increases expression ISO RGD:1320896 6480464 nefazodone results in increased expression of RIPK1 mRNA CTD PMID:32152650 nickel atom increases expression ISO RGD:1320896 6480464 Nickel results in increased expression of RIPK1 mRNA CTD PMID:25583101 o-anisidine increases expression ISO RGD:1320896 6480464 2-anisidine results in increased expression of RIPK1 mRNA CTD PMID:28089782 ochratoxin A decreases expression ISO RGD:1320896 6480464 ochratoxin A results in decreased expression of RIPK1 mRNA CTD PMID:30763683 omethoate decreases expression ISO RGD:1320896 6480464 dimethoxon results in decreased expression of RIPK1 mRNA CTD PMID:26688254 osthole increases expression ISO RGD:1320896 6480464 osthol results in increased expression of RIPK1 protein CTD PMID:29319219 p-menthan-3-ol increases expression ISO RGD:1320896 6480464 Menthol results in increased expression of RIPK1 mRNA CTD PMID:26760959 paracetamol multiple interactions ISO RGD:1320897 6480464 [RIPK1 protein affects the susceptibility to Acetaminophen] which affects the expression of TNFAIP3 protein more ... CTD PMID:24440347 , PMID:33460648 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RIPK1 mRNA CTD PMID:33387578 paracetamol affects response to substance ISO RGD:1320897 6480464 RIPK1 protein affects the susceptibility to Acetaminophen CTD PMID:33460648 paracetamol increases expression ISO RGD:1320896 6480464 Acetaminophen results in increased expression of RIPK1 mRNA CTD PMID:25704631 paracetamol increases expression ISO RGD:1320897 6480464 Acetaminophen results in increased expression of RIPK1 protein CTD PMID:24440347 paraquat multiple interactions ISO RGD:1320897 6480464 [Maneb co-treated with Paraquat] results in increased expression of RIPK1 mRNA, Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of RIPK1 mRNA] CTD PMID:23963992 parathion-methyl decreases expression ISO RGD:1320896 6480464 Methyl Parathion results in decreased expression of RIPK1 mRNA CTD PMID:26688254 PCB138 multiple interactions ISO RGD:1320897 6480464 2 more ... CTD PMID:29704545 pentachlorophenol increases expression ISO RGD:1320897 6480464 Pentachlorophenol results in increased expression of RIPK1 mRNA CTD PMID:23892564 phenylephrine increases expression ISO RGD:1320896 6480464 Phenylephrine results in increased expression of RIPK1 protein CTD PMID:31605733 picoxystrobin decreases expression ISO RGD:1320896 6480464 picoxystrobin results in decreased expression of RIPK1 mRNA CTD PMID:33512557 pirinixic acid decreases expression ISO RGD:1320897 6480464 pirinixic acid results in decreased expression of RIPK1 mRNA CTD PMID:23811191 Pranoprofen increases expression ISO RGD:1320896 6480464 pyranoprofen results in increased expression of RIPK1 protein CTD PMID:31765691 propacetamol increases expression ISO RGD:1320897 6480464 propacetamol results in increased expression of RIPK1 protein CTD PMID:29574133 propacetamol multiple interactions ISO RGD:1320897 6480464 kaempferol inhibits the reaction [propacetamol results in increased expression of RIPK1 protein] CTD PMID:29574133 propylparaben increases expression ISO RGD:1320896 6480464 propylparaben results in increased expression of RIPK1 mRNA CTD PMID:24481588 pterostilbene multiple interactions ISO RGD:1320896 6480464 NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein]] more ... CTD PMID:34474091 quetiapine fumarate increases expression ISO RGD:1320897 6480464 Quetiapine Fumarate results in increased expression of RIPK1 protein CTD PMID:31220554 quetiapine fumarate multiple interactions ISO RGD:1320897 6480464 AM 281 inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK1 protein], Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK1 protein] CTD PMID:31220554 resveratrol decreases expression ISO RGD:1320897 6480464 resveratrol analog results in decreased expression of RIPK1 protein CTD PMID:15652768 resveratrol multiple interactions ISO RGD:1320896 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of RIPK1 mRNA, Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of RIPK1 mRNA] CTD PMID:23452621 , PMID:23557933 rimonabant multiple interactions ISO RGD:1320897 6480464 Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK1 protein] CTD PMID:31220554 rotenone decreases expression ISO RGD:1320896 6480464 Rotenone results in decreased expression of RIPK1 mRNA CTD PMID:29955902 Shikonin multiple interactions ISO RGD:1320897 6480464 shikonin promotes the reaction [RIPK1 protein binds to RIPK3 protein] CTD PMID:23261677 silicon dioxide increases expression ISO RGD:1320896 6480464 Silicon Dioxide results in increased expression of RIPK1 mRNA CTD PMID:32600046 silver atom decreases expression ISO RGD:1320896 6480464 Silver analog results in decreased expression of RIPK1 mRNA CTD PMID:24462830 silver(0) decreases expression ISO RGD:1320896 6480464 Silver analog results in decreased expression of RIPK1 mRNA CTD PMID:24462830 simvastatin multiple interactions ISO RGD:1320896 6480464 [Simvastatin co-treated with Metformin] promotes the reaction [RIPK3 protein binds to RIPK1 protein] more ... CTD PMID:25412314 SM-164 multiple interactions ISO RGD:1320896 6480464 [ZFP91 protein co-treated with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone co-treated with SM 164 co-treated with TNF protein] results in increased phosphorylation of RIPK1 protein CTD PMID:34942311 SM-164 multiple interactions ISO RGD:1320897 6480464 [benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone co-treated with SM 164 co-treated with TNF protein] results in increased phosphorylation of RIPK1 protein more ... CTD PMID:34942311 sodium arsenate increases expression ISO RGD:1320897 6480464 sodium arsenate results in increased expression of RIPK1 mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO RGD:1320897 6480464 sodium arsenite results in decreased expression of RIPK1 mRNA CTD PMID:31233874 sodium arsenite increases expression ISO RGD:1320897 6480464 sodium arsenite results in increased expression of RIPK1 protein CTD PMID:29763682 sodium arsenite multiple interactions ISO RGD:1320897 6480464 Melatonin inhibits the reaction [sodium arsenite results in increased expression of RIPK1 protein] CTD PMID:29763682 sodium sulfite increases expression ISO RGD:1320896 6480464 sodium sulfite results in increased expression of RIPK1 protein CTD PMID:23973939 Soman increases expression EXP 6480464 Soman results in increased expression of RIPK1 mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:1320896 6480464 Sunitinib results in decreased expression of RIPK1 mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1320896 6480464 Temozolomide results in increased expression of RIPK1 mRNA CTD PMID:31758290 tetrachloromethane multiple interactions ISO RGD:1320897 6480464 4-O-methylhonokiol inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in decreased expression of RIPK1 mRNA], [Ethanol co-treated with Carbon Tetrachloride] results in decreased expression of RIPK1 mRNA CTD PMID:28689299 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RIPK1 mRNA CTD PMID:34492290 Triptolide multiple interactions ISO RGD:1320897 6480464 [triptolide co-treated with Lipopolysaccharides] results in increased expression of RIPK1 protein, necrostatin-1 inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in increased expression of RIPK1 protein] CTD PMID:30633930 triptonide decreases expression ISO RGD:1320897 6480464 triptonide results in decreased expression of RIPK1 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1320897 6480464 Tungsten results in decreased expression of RIPK1 mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:1320896 6480464 Tunicamycin results in increased expression of RIPK1 mRNA CTD PMID:29453283 urethane increases expression ISO RGD:1320896 6480464 Urethane results in increased expression of RIPK1 mRNA CTD PMID:28818685 ursodeoxycholic acid multiple interactions ISO RGD:1320896 6480464 RIPK1 mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased activity of CASP8 protein] more ... CTD PMID:21362627 valproic acid affects expression ISO RGD:1320897 6480464 Valproic Acid affects the expression of RIPK1 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:1320896 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA CTD PMID:17183730 valproic acid decreases expression ISO RGD:1320897 6480464 Valproic Acid results in decreased expression of RIPK1 mRNA CTD PMID:21427059 vorinostat multiple interactions ISO RGD:1320896 6480464 [vorinostat co-treated with TNFSF10 protein] affects the localization of RIPK1 protein, benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] affects the localization of RIPK1 protein] CTD PMID:19643600 WIN 55212-2 decreases expression ISO RGD:1320896 6480464 (3R)-((2 more ... CTD PMID:30776504 zinc oxide increases expression ISO RGD:1320896 6480464 Zinc Oxide results in increased expression of RIPK1 mRNA CTD PMID:32600046
